BPA Call HT001414A0014-0003
Award Date 1/20/15
Potential Completion Date 9/30/15
Potential Value $250K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $150,000 firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Bureau of Medicine and Surgery, a Defense agency, to Broughton Pharmaceuticals, LLC, a for-profit limited liability company. The contract is for the provision of pharmaceutical shortage supplies, including products such as RYDAPT, Novolog insulin, Carimune, and oncological drugs, as well as personal protective equipment (PPE) like N95 masks and disinfectant wipes. This BPA call is part of a larger...
- This contract was awarded by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, GA. The $250,000 Blanket Purchase Agreement (BPA) call contract is for the provision of various pharmaceutical shortage items, including blood products, oncological pharmaceuticals, and other injectable, oral, and inhalation medications. The contract has a completion date of September 30, 2018 and uses a firm fixed price pricing type. Broughton...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company. The $500,000.00 contract is for the provision of various pharmaceutical shortage items, including blood products, oncology pharmaceuticals, and other injectable, oral, and inhalation medications. The contract has no set-aside designation and was awarded on August 28, 2017 with a completion date of September...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract has a ceiling value of $550,000.00 and a completion date of September 30, 2017. The contract is for the procurement of pharmaceutical products to address shortages, with no set-aside designation used. Broughton Pharmaceuticals is a vendor that specializes in pharmaceutical...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract, valued at $400,000.00, is for the delivery of shortage pharmaceuticals to support military medical centers. The contract does not utilize any set-aside designation, indicating open competition. Broughton Pharmaceuticals is an established federal contractor, having secured...
- Broughton Pharmaceuticals, LLC was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency (DHA) to provide shortage pharmaceuticals such as Carimune and oncological pharmaceuticals for Walter Reed National Military Medical Center in Bethesda, Maryland. Valued at one hundred fifty thousand U.S. dollars ($150,000), the contract has a period of performance through August 2021 and was awarded in August 2020 without a set-aside designation. As the DHA...
- This federal contract award, valued at $75,000.00, was issued by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract is a Blanket Purchase Agreement (BPA) call for the delivery of various pharmaceuticals, such as Amidate vials, Adrenaline 30ML MDV, and Atropine SYR, to support military healthcare operations. The contract has a firm fixed-price pricing type and an ultimate completion date of June 14,...
- This federal contract award to Broughton Pharmaceuticals, LLC is for the delivery of emergency blood-related products used in patient care. The contract has a ceiling value of $89,584.24 and was awarded by the Defense Health Agency (DHA), a defense agency. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type, and an ultimate completion date of July 16, 2020. The contract does not utilize any set-aside designations. Broughton Pharmaceuticals is a for-profit...
- This is a firm fixed-price contract awarded by the Defense Health Agency (DHA) to Broughton Pharmaceuticals, LLC, a for-profit limited liability company based in Savannah, Georgia. The contract is for the supply of various pharmaceutical shortage items, blood products, and oncological pharmaceutical products. The award has a ceiling value of $100,000.00 and an ultimate completion date of May 26, 2017. The contract was awarded on May 19, 2017 and does not have a set-aside designation,...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Defense's Bureau of Medicine and Surgery (BUMED) to Priority Pharmaceuticals, Inc. for $150,000.00. The contract is for the provision of "PHARMACEUTICAL SHORTAGE ITEMS" with a period of performance ending on September 30, 2014. The contract was not set aside for any particular business type. Based on the agency and description, this award is likely part of BUMED's efforts to address...